AmeriCann, Inc. Reports Earnings Results for the Full Year Ended September 30, 2021
December 06, 2021 at 07:46 am EST
Share
AmeriCann, Inc. reported earnings results for the full year ended September 30, 2021. For the full year, the company reported sales was USD 2.03 million compared to USD 0.503512 million a year ago. Net loss was USD 0.862893 million compared to USD 0.709343 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.03 a year ago. Diluted loss per share from continuing operations was USD 0.04 compared to USD 0.03 a year ago.
AmeriCann, Inc. is a cannabis company that develops cultivation, processing and product manufacturing facilities. It has provisional licenses to produce cannabis-infused products, including beverages, edibles, topicals and concentrates. It designs GMP-certified cannabis extraction and product manufacturing infrastructure. Its flagship project is the Massachusetts Cannabis Center (MCC), which is being developed on a 52-acre parcel. MCC project is permitted for over 800,000 square feet of cannabis cultivation and processing infrastructure which is being developed in phases to support both the existing medical cannabis and the emerging adult-use cannabis marketplace. The Company, through a 100% owned subsidiary, AmeriCann Brands, Inc., has received two licenses from the Massachusetts Cannabis Control Commission to cultivate cannabis and provide extraction and product manufacturing support to the entire MCC project, as well as to other licensed cannabis farmers throughout regulated market.
AMERICANN, INC. 
